spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

The CPhI Annual Report

CPhI Worldwide

Take part in pharma’s largest reputation survey

The global pharmaceutical landscape is evolving at an extraordinary pace as manufacturing capabilities, drug development technologies, and regulation advances creating new ways of innovating drugs and better serving patients.

CPhI Worldwide is using its unrivalled access to pharmaceutical professionals and supplier companies to produce its third annual global survey of the major trends, changes and developments in the industry. This invaluable research will rank the relative reputations of the major pharma economies – from China and India to the USA, Japan, and Europe – creating pharma league tables across areas such as ‘API production’, ‘finished dosage formulations’, ‘biologics’, ‘growth potential’, ‘innovation’ ‘regulatory acumen’, and ‘drug delivery technology’ amongst others.

Covering small molecule, biologics and drug delivery and packaging, the insights provided are integral to building a global picture of the state and strength of the international pharma industry. Investment decisions and supply-side arrangements can often hinge on this unspoken influence, particularly when working with new partners.

The Report provides the industry with an in-depth, holistic analysis that will help you make better-informed decisions and meet the evolving pharma business landscape.

The results of this survey are completely anonymous and will be available on the CPhI Annual Report webpage. Please take the survey here: https://www.surveymonkey.co.uk/r/CPhIAnnual19

For media enquiries, please contact:

Alex Heeley or Abdul Khalifeh
De Facto Communications
T: +44 (0) 203 735 8168
E: a.heeley@defacto.com / a.khalifeh@defacto.com
phone +31 (0)20 708 1637
email cphicustomerservice@ubm.com
web www.cphi.com
email Delhi, India
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Turkish Cargo maintains its steady growth.

According to the data obtained by WACD, the international air cargo information provider, in May; Turkish Cargo, the global air cargo brand providing service to 124 countries around the world, increased its tonnage rate by 7.1 percent, and grew substantially across the industry which shrank by 5.1 percent in the global air cargo market.
More info >>


White Papers

Sourcing Commercial Drugs for Clinical Trials: US vs. EU Understanding the Differences

Myoderm

Sourcing commercial drugs for clinical trials is a dynamic process. There are many factors to consider: single source or regional sourcing, strategy, price, supply availability, lead times, and documentation are just a few. In the past, there were fewer clinical trials that required commercial drug sourcing, so demand was not as high. Today, the demand for commercial drugs in clinical trials has greatly increased and, as a result, inventory is tighter, orders are monitored more closely by manufacturers, and lead times have increased. This report highlights the key differences in sourcing from the US and EU.
More info >>

Industry Events

Outsourcing in Clinical Trials Europe

6-7 May 2020, Paris, France

Arena International are delighted to announce the return of Outsourcing in Clinical Trials Europe. Part of our global series of events, this flagship show will attract the leading clinical professionals from across Europe. The 10th Annual event will be hosted in Paris.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement